Cargando…

Estimation of individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes

AIMS/HYPOTHESIS: Intensive glucose control reduces the risk of vascular complications while increasing the risk of severe hypoglycaemia at a group level. We sought to estimate individual beneficial and adverse effects of intensive glucose control in patients with type 2 diabetes. METHODS: We perform...

Descripción completa

Detalles Bibliográficos
Autores principales:	van der Leeuw, Joep, Visseren, Frank L. J., Woodward, Mark, van der Graaf, Yolanda, Grobbee, Diederick E., Harrap, Stephen, Heller, Simon, Mancia, Giuseppe, Marre, Michel, Poulter, Neil, Zoungas, Sophia, Chalmers, John
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6518074/ https://www.ncbi.nlm.nih.gov/pubmed/27586250 http://dx.doi.org/10.1007/s00125-016-4082-5

Ejemplares similares

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2017)

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2021)

The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial
por: Nguyen, Tu N., et al.
Publicado: (2021)

The harms of smoking and benefits of smoking cessation in women compared with men with type 2 diabetes: an observational analysis of the ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron modified release Controlled Evaluation) trial
por: Blomster, Juuso I, et al.
Publicado: (2016)

Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial
por: Zoungas, Sophia, et al.
Publicado: (2009)

Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
por: Mohammedi, Kamel, et al.
Publicado: (2016)

Polygenic risk scores predict diabetes complications and their response to intensive blood pressure and glucose control
por: Tremblay, Johanne, et al.
Publicado: (2021)

Relationship Between Plasma 8‐OH‐Deoxyguanosine and Cardiovascular Disease and Survival in Type 2 Diabetes Mellitus: Results From the ADVANCE Trial
por: Thomas, Merlin C., et al.
Publicado: (2018)

Resting Heart Rate and the Risk of Microvascular Complications in Patients With Type 2 Diabetes Mellitus
por: Hillis, Graham S., et al.
Publicado: (2012)

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial
por: van Steen, Sigrid C., et al.
Publicado: (2018)

Does Glycemic Control Offer Similar Benefits Among Patients With Diabetes in Different Regions of the World?: Results from the ADVANCE trial
por: Woodward, Mark, et al.
Publicado: (2011)

Associations between body mass index and the risk of renal events in patients with type 2 diabetes
por: Mohammedi, Kamel, et al.
Publicado: (2018)

Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials
por: Hua, X., et al.
Publicado: (2020)

Comment on Vistisen et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care 2021;44:901–907
por: Østergaard, Helena Bleken, et al.
Publicado: (2021)

Excess Early Postnatal Weight Gain Leads to Increased Abdominal Fat in Young Children
por: Evelein, Annemieke M. V., et al.
Publicado: (2012)

Effects of the Endpoint Adjudication Process on the Results of a Randomised Controlled Trial: The ADVANCE Trial
por: Hata, Jun, et al.
Publicado: (2013)

Unrequested information from routine diagnostic chest CT predicts future cardiovascular events
por: Jacobs, Peter C., et al.
Publicado: (2011)

The relationship between eGFR slope and subsequent risk of vascular outcomes and all-cause mortality in type 2 diabetes: the ADVANCE-ON study
por: Oshima, Megumi, et al.
Publicado: (2019)

The relation between body fat distribution, plasma concentrations of adipokines and the metabolic syndrome in patients with clinically manifest vascular disease
por: Schrover, Ilse M, et al.
Publicado: (2018)

PPARγ Variant Influences Angiographic Outcome and 10-Year Cardiovascular Risk in Male Symptomatic Coronary Artery Disease Patients
por: Regieli, Jakub J., et al.
Publicado: (2009)

Peroxisome proliferator-activated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: A case-cohort study and meta-analyses
por: Zafarmand, Mohammad Hadi, et al.
Publicado: (2008)

The M235T Polymorphism in the AGT Gene and CHD Risk: Evidence of a Hardy-Weinberg Equilibrium Violation and Publication Bias in a Meta-Analysis
por: Zafarmand, Mohammad Hadi, et al.
Publicado: (2008)

Plasma fatty acids and the risk of vascular disease and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE study
por: Harris, Katie, et al.
Publicado: (2020)

Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials
por: de Jong, Marit, et al.
Publicado: (2017)

Novel Biomarkers to Improve the Prediction of Cardiovascular Event Risk in Type 2 Diabetes Mellitus
por: van der Leeuw, Joep, et al.
Publicado: (2016)

Inquiry-Based Learning and Conceptual Change in Balance Beam Understanding
por: van der Graaf, Joep
Publicado: (2020)

A systematic breakdown of the levels of evidence supporting the European Society of Cardiology guidelines
por: van Dijk, Wouter B, et al.
Publicado: (2019)

Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. The SMART study
por: Verhagen, Sandra N, et al.
Publicado: (2011)

The daily 10 kcal expenditure deficit: a before-and-after study on low-cost interventions in the work environment
por: Dorresteijn, Johannes A N, et al.
Publicado: (2013)

When is it impractical to ask informed consent? A systematic review
por: Laurijssen, Sara JM, et al.
Publicado: (2022)

Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients
por: Stam-Slob, Manon C., et al.
Publicado: (2016)

Predictors of adverse events after endovascular abdominal aortic aneurysm repair: A meta-analysis of case reports
por: Schlösser, Felix JV, et al.
Publicado: (2008)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
por: Welsh, Paul, et al.
Publicado: (2018)

Cost‐Effectiveness of Intensifying Lipid‐Lowering Therapy With Statins Based on Individual Absolute Benefit in Coronary Artery Disease Patients
por: Stam‐Slob, Manon C., et al.
Publicado: (2017)

Would treatment decisions about secondary prevention of CVD based on estimated lifetime benefit rather than 10-year risk reduction be cost-effective?
por: Berkelmans, Gijs F. N., et al.
Publicado: (2020)

The willingness to participate in biomedical research involving human beings in low‐ and middle‐income countries: a systematic review
por: Browne, Joyce L., et al.
Publicado: (2019)

Comparison of Circulating Biomarkers in Predicting Diabetic Kidney Disease Progression With Autoantibodies to Erythropoietin Receptor
por: Oshima, Megumi, et al.
Publicado: (2020)

Cardiovascular guidelines based on high-quality evidence: Are we getting there?
por: van Dijk, Wouter B, et al.
Publicado: (2019)

The effect of computerized decision support systems on cardiovascular risk factors: a systematic review and meta-analysis
por: Groenhof, T. Katrien J., et al.
Publicado: (2019)

Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials
por: Heerspink, Hiddo J Lambers, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_lj0gfmob1p4j7uk7u157j9s4r2